← Leaderboards
Andreas Friedl
University Of Wisconsin Madison
$5,279,011
Attributed
$5,986,763
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $670.2K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,986,763 · 5
VA$0 · 1
By mechanism
R01$5,801,873 · 4
R21$184,890 · 1
I01$0 · 1
Top collaborators
- Klaus Michael Hahn4 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Eric V Shusta$15,385,532
- Tomy Varghese$7,667,600
- Ward C Tucker$2,225,835
- Jordan R Green$13,993,816
- Nimmi Ramanujam$17,436,488
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoGrowthIn VitroAnimalsSignal PathwayTumorEventSignal TransductionEndothelial CellsLaboratoriesRegulationBiologyCell SurfaceMalignant NeoplasmsMolecularCancer CellDesignCellsBaseMediatingCell MotilityLeadPublic Health RelevancePathway Interactions
Grant awards (29)
Mechanisms Of Cell Migration On 3D Aligned Matrices$356,559
R01 · FY2020 · CA · contact PI
Mechanisms Of Cell Migration On 3D Aligned Matrices$345,863
R01 · FY2019 · CA · contact PI
Mechanisms Of Cell Migration On 3D Aligned Matrices$356,559
R01 · FY2018 · CA · contact PI
Trafficking and Endosomal Sorting of APP and BACE-1$313,650
R01 · FY2018 · AG · contact PI
Mechanisms Of Cell Migration On 3D Aligned Matrices$356,524
R01 · FY2017 · CA · contact PI
A CRISPR-Cas9 screen to identify genetic modifiers of APP/BACE-1 interactions$184,890
R21 · FY2017 · AG · contact PI
Glypican-1 in gliomagenesis$0
I01 · FY2016 · VA · contact PI
Glypican-1 in gliomagenesis$0
I01 · FY2015 · VA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$279,739
R01 · FY2014 · CA · contact PI
Glypican-1 in gliomagenesis$0
I01 · FY2014 · VA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$271,088
R01 · FY2013 · CA · contact PI
Glypican-1 in gliomagenesis$0
I01 · FY2013 · VA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$288,391
R01 · FY2012 · CA · contact PI
STATs as Key Targets in Tumor Angiogenesis$0
I01 · FY2012 · VA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$288,391
R01 · FY2011 · CA · contact PI
STATs as Key Targets in Tumor Angiogenesis$0
I01 · FY2011 · VA · contact PI
STATs as Key Targets in Tumor Angiogenesis$0
I01 · FY2011 · VA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$297,310
R01 · FY2010 · CA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$269,030
R01 · FY2009 · CA · contact PI
STATs as Key Targets in Tumor Angiogenesis$0
I01 · FY2009 · VA · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$269,300
R01 · FY2008 · CA · contact PI
Heparan Sulfate Proteoglycans in Glioma Angiogenesis$245,360
R01 · FY2008 · NS · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$269,565
R01 · FY2007 · CA · contact PI
Heparan Sulfate Proteoglycans in Glioma Angiogenesis$245,647
R01 · FY2007 · NS · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$277,883
R01 · FY2006 · CA · contact PI
Heparan Sulfate Proteoglycans in Glioma Angiogenesis$253,271
R01 · FY2006 · NS · contact PI
Syndecan-1 in Stromal Fibroblasts of Breast Carcinomas$294,167
R01 · FY2005 · CA
Heparan Sulfate Proteoglycans in Glioma Angiogenesis$259,876
R01 · FY2005 · NS
Heparan Sulfate Proteoglycans in Glioma Angiogenesis$263,700
R01 · FY2004 · NS